Caprock Group LLC bought a new position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 26,279 shares of the company’s stock, valued at approximately $677,000.
A number of other institutional investors have also recently made changes to their positions in BBWI. Parkside Financial Bank & Trust raised its stake in Bath & Body Works by 24.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after acquiring an additional 364 shares during the period. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Bath & Body Works by 3.7% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 16,700 shares of the company’s stock worth $430,000 after purchasing an additional 600 shares in the last quarter. State of Wyoming raised its position in shares of Bath & Body Works by 6.2% in the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock valued at $338,000 after purchasing an additional 661 shares during the period. Vident Advisory LLC lifted its stake in shares of Bath & Body Works by 2.8% during the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock valued at $756,000 after buying an additional 692 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its stake in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on BBWI shares. Barclays boosted their target price on shares of Bath & Body Works from $18.00 to $20.00 and gave the company an “equal weight” rating in a report on Tuesday, January 6th. Citigroup decreased their price objective on Bath & Body Works from $35.00 to $21.00 and set a “buy” rating on the stock in a research note on Friday, November 21st. Telsey Advisory Group downgraded Bath & Body Works from an “outperform” rating to a “market perform” rating and cut their target price for the stock from $38.00 to $17.00 in a research note on Friday, November 21st. Jefferies Financial Group began coverage on Bath & Body Works in a report on Wednesday, January 14th. They set a “hold” rating and a $24.00 target price for the company. Finally, Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, November 12th. Five investment analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $22.93.
Bath & Body Works Stock Up 5.3%
NYSE:BBWI opened at $24.07 on Tuesday. The stock has a market cap of $4.93 billion, a P/E ratio of 7.41, a PEG ratio of 1.06 and a beta of 1.54. The business’s 50-day moving average price is $21.44 and its two-hundred day moving average price is $24.01. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $41.87.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings data on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the company posted $0.49 earnings per share. The firm’s revenue for the quarter was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. On average, equities research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 6th. Stockholders of record on Friday, February 20th will be given a dividend of $0.20 per share. The ex-dividend date is Friday, February 20th. This represents a $0.80 annualized dividend and a dividend yield of 3.3%. Bath & Body Works’s dividend payout ratio (DPR) is 24.62%.
Insider Activity at Bath & Body Works
In other news, Director Francis Hondal acquired 3,343 shares of Bath & Body Works stock in a transaction dated Friday, November 21st. The shares were purchased at an average cost of $14.99 per share, for a total transaction of $50,111.57. Following the transaction, the director owned 21,554 shares of the company’s stock, valued at $323,094.46. This trade represents a 18.36% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Lucy Brady bought 3,470 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The stock was purchased at an average price of $14.40 per share, with a total value of $49,968.00. Following the transaction, the director directly owned 17,482 shares in the company, valued at $251,740.80. The trade was a 24.76% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders purchased 33,513 shares of company stock valued at $500,442. 0.27% of the stock is currently owned by insiders.
More Bath & Body Works News
Here are the key news stories impacting Bath & Body Works this week:
- Negative Sentiment: Multiple law firms have either filed or are soliciting plaintiffs in a securities class action against Bath & Body Works alleging violations of Sections 10(b) and 20(a) and Rule 10b‑5, covering purchases between June 4, 2024 and November 19, 2025; lead‑plaintiff deadlines are being advertised around March 13–16, 2026. These notices signal active litigation and potential future settlement or judgment exposure. DJS Law Group Notice Rosen Law Firm Notice Kessler Topaz Notice
Bath & Body Works Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
